Nuzenio

Tradingview Auph

Tradingview Auph entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Thu, 06 Aug 2026 12:21:02 GMTAurinia Pharmaceuticals Inc. 2026: Revenue $83.22M, EPS $0.28— 10-Q Summary - TradingView
Thu, 06 Aug 2026 12:19:11 GMTAUPH: Strong revenue and profit growth fueled by LUPKYNIS sales and disciplined capital allocation - TradingView
Thu, 06 Aug 2026 12:13:01 GMTAurinia Pharmaceuticals posts Q2 revenue $83.2M, net income $37.4M; reiterates 2026 guidance - TradingView
Thu, 06 Aug 2026 12:06:38 GMTAUPH: Strong revenue and net income growth driven by LUPKYNIS, with robust 2026 outlook - TradingView
Thu, 06 Aug 2026 12:01:01 GMTBRIEF-Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million - TradingView
Sat, 01 Aug 2026 06:09:33 GMTAurinia Pharmaceuticals Inc Revenue Breakdown – NASDAQ:AUPH - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Auph.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.